Reviewing Heyu Biological Technology (OTCMKTS:HYBT) and Pixie Dust Technologies (NASDAQ:PXDT)

Pixie Dust Technologies (NASDAQ:PXDT) and Heyu Biological Technology (OTCMKTS:HYBT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, earnings, risk and dividends.

Analyst Recommendations

This is a summary of current ratings and target prices for Pixie Dust Technologies and Heyu Biological Technology, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pixie Dust Technologies	0	0	1	0	3.00
Heyu Biological Technology	0	0	0	0	N/A

Pixie Dust Technologies presently has a consensus target price of $5.21, suggesting a potential upside of 100.38%. Given Pixie Dust Technologies’ higher probable upside, equities analysts clearly believe Pixie Dust Technologies is more favorable than Heyu Biological Technology.

Profitability

This table compares Pixie Dust Technologies and Heyu Biological Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pixie Dust Technologies	N/A	N/A	N/A
Heyu Biological Technology	-453.55%	-6.43%	-4.43%

Institutional and Insider Ownership

0.4% of Pixie Dust Technologies shares are owned by institutional investors. 89.2% of Heyu Biological Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Pixie Dust Technologies and Heyu Biological Technology’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pixie Dust Technologies	$5.18 million	7.38	-$14.45 million	N/A	N/A
Heyu Biological Technology	$80,000.00	287.28	-$270,000.00	N/A	N/A

Heyu Biological Technology has lower revenue, but higher earnings than Pixie Dust Technologies.

Summary

Pixie Dust Technologies beats Heyu Biological Technology on 7 of the 10 factors compared between the two stocks.

About Pixie Dust Technologies

Pixie Dust Technologies, Inc., a technology company, focuses on personal care and diversity, and workspace and digital transformation businesses primarily in Japan. It offers SonoRepro, an ultrasonic non-contact vibrotactile stimulation scalp care device; VUEVO, a series of directional voice arrival detection devices for individuals with deaf and hard-of-hearing; and kikippa, an acoustic stimulation device functioning as a desk-top speaker. The company also provides iwasemi, a sound-absorbing or sound-proofing material for architectural and interior design firms; hackke, a location positioning technology; KOTOWARI, a technology offering spatial analysis data; and magickiri, a planning services and monitoring service, which monitors human behavior and analyzes the customer's environment on the customer's behalf. In addition, it operates Pixie Nest, a membership forum, which hosts meetings and distributes information to facilitate solving social issues. The company was incorporated in 2017 and is headquartered in Tokyo, Japan.

About Heyu Biological Technology

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.